LGALS3 and Alzheimer disease: TREM2, a receptor with established genetic ties to AD, binds Gal3 directly, a partnership critical for microglial survival, metabolic regulation, and the emergence of DAM phenotypes around plaques (Boza-Serrano et al., 2019).